Josias Pontes

VP, Head of Finance, Sigilon Therapeutics, Inc.

Companies

Sigilon Therapeutics, Inc.Chief financial officer Feb 22, 2022 to Aug 11, 2023¹
Sigilon Therapeutics, Inc.VP, Head of Finance Jun 21, 2021 to Jan 4, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Sigilon Therapeutics, Inc.0 shares³Aug 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 11, 2023Returned to company 3,504 shares of Sigilon Therapeutics, Inc.³
Jul 21, 2023Exercised options 1,444 shares at $19.24 of Sigilon Therapeutics, Inc.⁴
Sep 30, 2021Granted 11,500 shares of Sigilon Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSigilon Therapeutics, Inc., Chief financial officer
2
SEC EDGARSigilon Therapeutics, Inc., VP, Head of Finance
3
SEC EDGARSigilon Therapeutics, Inc. shares after the filing of Aug 11, 2023
4
SEC EDGARForm 4 filed Jul 24, 2023
5
SEC EDGARForm 4 filed Oct 4, 2021